Amgen’s biotechnology focuses on oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. As one of the world's leading biotechnology firms, Amgen deeply roots itself in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. As its products strive to improve the lives of those affected by these medical conditions, Amgen’s diverse product range caters to various therapeutic areas.
Founded in Thousand Oaks, California, Amgen has grown to employ 22,000 individuals and generate annual revenue of $26.3 billion under the leadership of CEO Robert A. Bradway. The company takes pride in its diverse workforce, which includes 43.4% female and 50.7% ethnic minority employees. This dedication to diversity extends to political affiliations as well; 74% of Amgen employees are members of the Democratic Party. The average employee at Amgen earns $93,349 per year and stays with the company for an average of 5.7 years, showcasing the company's commitment to retaining top talent.
